| Literature DB >> 32238173 |
Sharada Weir1, Mihail Samnaliev2, Tzu-Chun Kuo3, Travis S Tierney4, Andrea Manca5, Rod S Taylor6, Julie Bruce7, Sam Eldabe8, David Cumming9.
Abstract
PURPOSE: To compare rates of persistent postoperative pain (PPP) after lumbar spine surgery-commonly known as Failed Back Surgery Syndrome-and healthcare costs for instrumented lumbar spinal fusion versus decompression/discectomy.Entities:
Mesh:
Year: 2020 PMID: 32238173 PMCID: PMC7114788 DOI: 10.1186/s13018-020-01633-6
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Criteria for evidence of persistent postoperative pain after index lumbar surgery
| Any one or more of the following | |
|---|---|
| HES inpatient | Any lumbar surgery: OPCS code 6–24 months post index surgery |
| HES inpatient/HES outpatient/CPRD Gold | Any surgical intervention for lumbar pain (e.g., neuromodulation, implantation of drug infusion delivery system): OPCS code or READ code at any time post index surgery |
| HES outpatient/CPRD Gold | At least one pain-related GP visit or specialist pain clinic visit in each of two consecutive quarters occurring 6–24 months post index surgery |
Characteristics of instrumented spine patients (cases) versus others (controls) before and after matching
| Full sample | Matched case-controls | |||||
|---|---|---|---|---|---|---|
| Non-instrumented | Instrumented | Non-instrumented | Instrumented | |||
| Age, years | 54.9 | 51.8 | .001 | 52.1 | 51.8 | .90 |
| Gender, % | 49.8 | 57.8 | .006 | 62.8 | 57.8 | .20 |
| Myocardial infarction, % | 2.6 | 0.9 | .07 | 1.25 | 0.9 | .70 |
| Congestive heart failure, % | 0.9 | 0.9 | .96 | 1.6 | 0.9 | .48 |
| Peripheral vascular disease, % | 2.0 | 2.2 | .81 | 0.9 | 2.2 | .20 |
| Cerebrovascular disease, % | 1.7 | 1.9 | .85 | 1.6 | 1.9 | .76 |
| Dementia, % | 0.1 | 0.3 | .43 | 0.3 | 0.3 | 1.0 |
| Chronic pulmonary disease, % | 12.3 | 13.1 | .66 | 11.9 | 13.1 | .63 |
| Connective tissue disease-rheumatic disease, % | 2.8 | 4.7 | .05 | 2.8 | 4.7 | .21 |
| Peptic ulcer disease, % | 1.4 | 2.5 | .13 | 1.6 | 2.5 | .40 |
| Mild liver disease, % | 0.6 | 0.0 | .16 | 0.0 | 0.0 | 1.0 |
| Diabetes without complications | 7.4 | 6.2 | .43 | 4.4 | 6.2 | .29 |
| Diabetes with complications, % | 0.6 | 0.6 | .98 | .6 | 0.6 | 1.0 |
| Paraplegia and hemiplegia, % | 3.2 | 1.6 | .11 | 1.6 | 1.6 | 1.0 |
| Renal disease, % | 1.3 | 0.6 | .29 | 0.0 | 0.6 | .16 |
| Cancer, % | 4.0 | 3.4 | .63 | 2.2 | 3.4 | .34 |
| Moderate or severe liver disease, % | 0.02 | 0.0 | .79 | 0.0 | 0.0 | 1.1 |
| Metastatic carcinoma, % | 0.4 | 0.6 | .57 | 0.3 | 0.6 | .56 |
PPP rates and 2-year postoperative costs, instrumented (cases) versus non-instrumented (age- and sex-matched controls)
| Non-instrumented | Instrumented | Odds ratio/cost difference [95% CI] | |
|---|---|---|---|
| Number of observations | 320 | 320 | |
| PPP | |||
| Number (%) | 69 (21.6%) | 62 (19.4%) | 0.876 [0.595–1.284] |
| Index hospitalization cost | |||
| Mean | £4345 | £8484 | £4139 [£3737–£4563] |
| 2-year follow-up cost | |||
| Mean | £7597 | £9423 | £1826 [£285–£3244] |
| Total cost | |||
| Mean | £11,942 | £17,907 | £5695 [£4505–£7528] |